GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for thioredoxin reductase 2, mitochondrial (Q9VNT5)

Analyse AlphaFold monomer V2.0 prediction for thioredoxin reductase 2, mitochondrial… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q9VNT5
Type
protein
Length
516 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x1ED4a68B4011314730adE976b56Ad4cA21b54dcD
Molecule
Thioredoxin reductase 2, mitochondrial
UniProt
Q9VNT5
Pockets
5 · best druggability 0.79

Structure

1 distinct chain · 32% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThioredoxin reductase 2, mitochondrialprotein51632% helix, 23% strandQ9VNT5

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110790.790.81118empty
2740.430.8116empty
31020.400.7619empty
41210.380.7324empty
5660.310.7415empty

Modifications

Observed in the structure: 1 disulfide (disulfide).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.